PhaseV
Agent42Agent Readiness: 42/100. Above median. Measured by StartupHub.ai. Median 41.Develops a platform for adaptive clinical trial design and closed-loop execution.
About
PhaseV provides AI/ML-driven solutions to optimize clinical development for biopharma sponsors and CROs. Their platform offers tools like Trial Optimizer, Response Optimizer, Portfolio Optimizer, and ClinOps Optimizer to improve trial design, decision-making, and operations, leading to faster, more efficient, and accurate clinical trials. PhaseV aims to increase trial success rates, enable sharper strategic decisions, and optimize the use of existing data.
Key facts
At-a-glance profile data
- Website
- phasevtrials.com
- Headquarters
- Tel Aviv, Israel
- Founded
- 2023
- Employees
- 61
- Total funding
- $65M (Series A)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 13 May 2025 | Series A | $50M | Accel Partners, Insight Partners |
| 24 Oct 2023 | Seed | $15M | Viola Ventures |
Tech stack
Detected on phasevtrials.com, last scanned 29 Sept 2026. Run your own scan
- Analytics
- Google Analytics 4
- CMS / Builders
- Webflow
- CDN
- Cloudflare
- Email provider
- Google Workspace
Frequently asked
How much funding has PhaseV raised?
PhaseV has raised a total of $65M in funding. The most recent round on record is Series A.
How many employees does PhaseV have?
PhaseV has approximately 61 people on record.